Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 18, 2025
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $16.00 as of July 25, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
16.00
Enterprise Value
n/a
Revenue
4.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 16.00, a decrease of -100.00%. That is a compound annual growth rate of -38.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.81M |
| Glass House Brands | 411.26M |
| Northwest Biotherapeutics | 382.85M |
| CytoDyn | 362.86M |